We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$118B
AUM Growth
+$8.21B
Cap. Flow
+$1.08B
Cap. Flow %
0.91%
Top 10 Hldgs %
16.3%
Holding
2,665
New
135
Increased
1,412
Reduced
606
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 16.35%
2 Financials 15.6%
3 Healthcare 12.81%
4 Consumer Discretionary 10.96%
5 Communication Services 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONIT
2351
Onity Group
ONIT
$309M
$109K ﹤0.01%
2,327
CLDX icon
2352
Celldex Therapeutics
CLDX
$2.99B
$109K ﹤0.01%
2,560
ICF icon
2353
iShares Select U.S. REIT ETF
ICF
$2.09B
$106K ﹤0.01%
2,090
RIGL icon
2354
Rigel Pharmaceuticals
RIGL
$681M
$105K ﹤0.01%
+2,700
New +$103K
WAIR
2355
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$104K ﹤0.01%
14,100
RRTS
2356
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$103K ﹤0.01%
536
NVAX icon
2357
Novavax
NVAX
$1.2B
$103K ﹤0.01%
4,155
LUMO
2358
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$100K ﹤0.01%
1,370
NVTA
2359
DELISTED
Invitae Corporation
NVTA
$98.1K ﹤0.01%
10,800
EVRI
2360
DELISTED
Everi Holdings
EVRI
$98K ﹤0.01%
+13,000
New +$105K
RSP icon
2361
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$96K ﹤0.01%
950
PACB icon
2362
Pacific Biosciences
PACB
$435M
$94K ﹤0.01%
35,620
KG
2363
Kestrel Group
KG
$69.4M
$93.7K ﹤0.01%
710
RBBN icon
2364
Ribbon Communications
RBBN
$377M
$93.2K ﹤0.01%
12,058
BKS
2365
DELISTED
Barnes & Noble
BKS
$93.1K ﹤0.01%
13,899
SID icon
2366
Companhia Siderúrgica Nacional
SID
$1.31B
$91.9K ﹤0.01%
+37,500
New +$96.7K
CALA
2367
DELISTED
Calithera Biosciences, Inc
CALA
$91.8K ﹤0.01%
+550
New +$141K
ATCO
2368
DELISTED
Atlas Corp.
ATCO
$91.1K ﹤0.01%
+13,500
New +$88.1K
ERII icon
2369
Energy Recovery
ERII
$446M
$88K ﹤0.01%
10,060
EGIO
2370
DELISTED
Edgio, Inc. Common Stock
EGIO
$87.8K ﹤0.01%
+498
New +$98.3K
BWX icon
2371
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.33B
$87K ﹤0.01%
3,060
-302
-9% -$8.49K
IGIB icon
2372
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$83.3K ﹤0.01%
1,526
+1,030
+208% +$56.4K
IOVA icon
2373
Iovance Biotherapeutics
IOVA
$1.82B
$82.1K ﹤0.01%
10,261
SDY icon
2374
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$81.2K ﹤0.01%
859
-14
-2% -$1.31K
VT icon
2375
Vanguard Total World Stock ETF
VT
$77.1B
$75.1K ﹤0.01%
+1,011
New +$73.5K

Similar funds

UBS AM's Q4 2017 Portfolio in Review

As of Q4 2017, UBS AM held 2,665 positions worth $118B, up 7.5% from $110B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS AM's Q4 2017 filing shows 135 new, 1,412 increased, 606 reduced and 93 closed positions. Its largest new stake was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M. The largest sale was Celgene Corp, an estimated $228M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q4 2017 buy was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M.
  • UBS AM added most to NetEase in Q4 2017, an estimated $383M increase.
  • UBS AM's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $228M.
  • UBS AM fully exited CR Bard Inc. in Q4 2017, selling an estimated $67.9M.
  • UBS AM's ten largest holdings make up 16% of its $118B portfolio in Q4 2017.
  • UBS AM opened 135 new positions and closed 93 in Q4 2017.
  • UBS AM's portfolio value rose 7.5% quarter-over-quarter to $118B.

Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.